Having trouble accessing articles? Reset your cache.

Alpharadin radium-223: Phase I/IIa started

Algeta began an open-label, U.S. Phase I/IIa trial to evaluate docetaxel plus IV Alpharadin

Read the full 141 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE